Developing personalized nanomedicine drug delivery systems

Project Pace

About Us

Artificial Intelligence for NanoMedicine

Aim

Our goal is to create the platform for rapid development of personalized nanomedicine drug delivery systems. We intend to do it by developing the intellectual property of EVO-NANO results in accordance to market and regulatory demands.

Origin

We build upon the computational platform that is under development in H2020 FET-Open project EVO-NANO. The platform uses AI to loud generate and in silico test novel cancer treatments.

Objectives

IP Positioning

Macro Market Analysis

Application Analysis

Market Strategy

Exploitation

Igor Balaz

Biophysicist at University of Novi Sad

Marina Kovacevic

Computational chemist at University of Novi Sad

Lance Leverette

Professional market researcher and analyst